Chronic Pain and Mental Health Disorders: Shared Neural Mechanisms, Epidemiology, and Treatment

Mayo Clinic Proceedings

Volumn 91, Issue 7, 2016, Pages 955-970

  Hooten, W Michael ^a  

^a Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; DULOXETINE; GABAPENTIN; MILNACIPRAN; NORTRIPTYLINE; PREGABALIN; VENLAFAXINE; NARCOTIC ANALGESIC AGENT; PSYCHOTROPIC AGENT;

ANXIETY DISORDER; BECK ANXIETY INVENTORY; BECK DEPRESSION INVENTORY; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CHRONIC PAIN; COGNITIVE BEHAVIORAL THERAPY; DEPRESSION; DIABETIC NEUROPATHY; DRUG DEPENDENCE; FEAR; FIBROMYALGIA; GENERALIZED ANXIETY DISORDER; HAMILTON DEPRESSION RATING SCALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR DEPRESSION; META ANALYSIS; MUSCULOSKELETAL PAIN; NEUROBIOLOGY; PANIC; PATIENT ATTITUDE; PATIENT HEALTH QUESTIONNAIRE 9; PERIPHERAL NEUROPATHY; PERSONALITY DISORDER; POSTHERPETIC NEURALGIA; PREVALENCE; PSYCHOSOCIAL REHABILITATION; REVIEW; SENSITIVITY AND SPECIFICITY; SEXUAL ABUSE; SEXUAL VIOLENCE; SMOKING; SOCIAL PHOBIA; SPINAL CORD INJURY; SUICIDE; SYSTEMATIC REVIEW; BEHAVIOR THERAPY; COMORBIDITY; MENTAL DISORDERS; NEURALGIA; OPIOID-RELATED DISORDERS; PATHOPHYSIOLOGY; PROCEDURES; TRENDS;

ANALGESICS, OPIOID; BEHAVIOR THERAPY; CHRONIC PAIN; COMORBIDITY; HUMANS; MENTAL DISORDERS; NEURALGIA; OPIOID-RELATED DISORDERS; PREVALENCE; PSYCHOTROPIC DRUGS;

EID: 84991585586     PISSN: 00256196     EISSN: 19425546     Source Type: Journal    
DOI: 10.1016/j.mayocp.2016.04.029     Document Type: Review

References (175)

1. 1 Henschke, N., Kamper, S.J., Maher, C.G., The epidemiology and economic consequences of pain. Mayo Clin Proc 90:1 (2015), 139–147.
2. 2 Kessler, R.C., Chiu, W.T., Demler, O., Merikangas, K.R., Walters, E.E., Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. [published correction appears in Arch Gen Psychiatry. 2005;62(7):709. Merikangas, Kathleen R [added]] Arch Gen Psychiatry 62:6 (2005), 617–627.
3. 3 Steel, Z., Marnane, C., Iranpour, C., et al. The global prevalence of common mental disorders: a systematic review and meta-analysis 1980-2013. Int J Epidemiol 43:2 (2014), 476–493.
4. 4 Hooten, W.M., Cohen, S.P., Evaluation and treatment of low back pain: a clinically focused review for primary care specialists. Mayo Clin Proc 90:12 (2015), 1699–1718.
5. 5 Melzack, R., Phantom limbs and the concept of a neuromatrix. Trends Neurosci 13:3 (1990), 88–92.
6. 6 Baliki, M.N., Apkarian, A.V., Nociception, pain, negative moods, and behavior selection. Neuron 87:3 (2015), 474–491.
7. 7 Garcia-Larrea, L., Peyron, R., Pain matrices and neuropathic pain matrices: a review. Pain 154:suppl 1 (2013), S29–S43.
8. 8 Choi, Y., Mayer, T.G., Williams, M.J., Gatchel, R.J., What is the best screening test for depression in chronic spinal pain patients?. Spine J 14:7 (2014), 1175–1182.
9. 9 Geisser, M.E., Roth, R.S., Robinson, M.E., Assessing depression among persons with chronic pain using the Center for Epidemiological Studies-Depression Scale and the Beck Depression Inventory: a comparative analysis. Clin J Pain 13:2 (1997), 163–170.
10. 10 Bjelland, I., Dahl, A.A., Haug, T.T., Neckelmann, D., The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 52:2 (2002), 69–77.
11. 11 Julian, L.J., Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A). Arthritis Care Res (Hoboken) 63:suppl 11 (2011), S467–S472.
12. 12 Leyfer, O.T., Ruberg, J.L., Woodruff-Borden, J., Examination of the utility of the Beck Anxiety Inventory and its factors as a screener for anxiety disorders. J Anxiety Disord 20:4 (2006), 444–458.
13. 13 Kroenke, K., Spitzer, R.L., Williams, J.B., Löwe, B., The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. Gen Hosp Psychiatry 32:4 (2010), 345–359.
14. 14 de Meneses-Gaya, C., Zuardi, A.W., Loureiro, S.R., Crippa, J.A., Alcohol Use Disorders Identification Test (AUDIT): An updated systematic review of psychometric properties. Psychol Neurosci 2:1 (2009), 83–97.
15. 15 Dhalla, S., Kopec, J.A., The CAGE questionnaire for alcohol misuse: a review of reliability and validity studies. Clin Invest Med 30:1 (2007), 33–41.
16. 16 Smith, S.M., Paillard, F., McKeown, A., et al. Instruments to identify prescription medication misuse, abuse, and related events in clinical trials: an ACTTION systematic review. J Pain 16:5 (2015), 389–411.
17. 17 Aguglia, A., Salvi, V., Maina, G., Rossetto, I., Aguglia, E., Fibromyalgia syndrome and depressive symptoms: comorbidity and clinical correlates. J Affect Disord 128:3 (2011), 262–266.
18. 18 Häuser, W., Jung, E., Erbslöh-Möller, B., et al. Validation of the Fibromyalgia Survey Questionnaire within a cross-sectional survey. PLoS One, 7(5), 2012, e37504.
19. 19 Raphael, K.G., Janal, M.N., Nayak, S., Schwartz, J.E., Gallagher, R.M., Psychiatric comorbidities in a community sample of women with fibromyalgia. Pain 124:1-2 (2006), 117–125.
20. 20 Thieme, K., Turk, D.C., Flor, H., Comorbid depression and anxiety in fibromyalgia syndrome: relationship to somatic and psychosocial variables. Psychosom Med 66:6 (2004), 837–844.
21. 21 Uguz, F., Ciçek, E., Salli, A., et al. Axis I and Axis II psychiatric disorders in patients with fibromyalgia. Gen Hosp Psychiatry 32:1 (2010), 105–107.
22. 22 Kudlow, P.A., Rosenblat, J.D., Weissman, C.R., et al. Prevalence of fibromyalgia and co-morbid bipolar disorder: a systematic review and meta-analysis. J Affect Disord 188 (2015), 134–142.
23. 23 Arnold, L.M., Hudson, J.I., Keck, P.E., Auchenbach, M.B., Javaras, K.N., Hess, E.V., Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry 67:8 (2006), 1219–1225.
24. 24 Giannakopoulos, N.N., Keller, L., Rammelsberg, P., Kronmüller, K.T., Schmitter, M., Anxiety and depression in patients with chronic temporomandibular pain and in controls. J Dent 38:5 (2010), 369–376.
25. 25 Manfredini, D., Borella, L., Favero, L., Ferronato, G., Guarda-Nardini, L., Chronic pain severity and depression/somatization levels in TMD patients. Int J Prosthodont 23:6 (2010), 529–534.
26. 26 Demyttenaere, K., Bruffaerts, R., Lee, S., et al. Mental disorders among persons with chronic back or neck pain: results from the World Mental Health Surveys. Pain 129:3 (2007), 332–342.
27. 27 Dersh, J., Gatchel, R.J., Mayer, T., Polatin, P., Temple, O.R., Prevalence of psychiatric disorders in patients with chronic disabling occupational spinal disorders. Spine (Phila Pa 1976) 31:10 (2006), 1156–1162.
28. 28 Reme, S.E., Tangen, T., Moe, T., Eriksen, H.R., Prevalence of psychiatric disorders in sick listed chronic low back pain patients. Eur J Pain 15:10 (2011), 1075–1080.
29. 29 Von Korff, M., Crane, P., Lane, M., et al. Chronic spinal pain and physical-mental comorbidity in the United States: results from the national comorbidity survey replication. Pain 113:3 (2005), 331–339.
30. 30 Van Oudenhove, L., Törnblom, H., Störsrud, S., Tack, J., Simrén, M., Depression and somatization are associated with increased postprandial symptoms in patients with irritable bowel syndrome. Gastroenterology 150:4 (2016), 866–874.
31. 31 Balliet, W.E., Edwards-Hampton, S., Borckardt, J.J., et al. Depressive symptoms, pain, and quality of life among patients with nonalcohol-related chronic pancreatitis. Pain Res Treat, 2012, 2012, 978646.
32. 32 de Heer, E.W., Gerrits, M.M., Beekman, A.T., et al. The association of depression and anxiety with pain: a study from NESDA. [published correction appears in PLoS One. 2014;9(12):e115077] PLoS One, 9(10), 2014, e106907.
33. 33 Berger, A., Dukes, E.M., Oster, G., Clinical characteristics and economic costs of patients with painful neuropathic disorders. J Pain 5:3 (2004), 143–149.
34. 34 Berger, A., Sadosky, A., Dukes, E., Edelsberg, J., Oster, G., Clinical characteristics and patterns of healthcare utilization in patients with painful neuropathic disorders in UK general practice: a retrospective cohort study. BMC Neurol, 12, 2012, 8.
35. 35 Gore, M., Dukes, E., Rowbotham, D.J., Tai, K.S., Leslie, D., Clinical characteristics and pain management among patients with painful peripheral neuropathic disorders in general practice settings. Eur J Pain 11:6 (2007), 652–664.
36. 36 Yawn, B.P., Wollan, P.C., Weingarten, T.N., Watson, J.C., Hooten, W.M., Melton, L.J. III, The prevalence of neuropathic pain: clinical evaluation compared with screening tools in a community population. [published correction appears in Pain Med. 2011;12(8):1294] Pain Med 10:3 (2009), 586–593.
37. 37 McWilliams, L.A., Cox, B.J., Enns, M.W., Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample. Pain 106:1-2 (2003), 127–133.
38. 38 McWilliams, L.A., Goodwin, R.D., Cox, B.J., Depression and anxiety associated with three pain conditions: results from a nationally representative sample. Pain 111:1-2 (2004), 77–83.
39. 39 Oedegaard, K.J., Neckelmann, D., Mykletun, A., et al. Migraine with and without aura: association with depression and anxiety disorder in a population-based study: the HUNT Study. Cephalalgia 26:1 (2006), 1–6.
40. 40 Saunders, K., Merikangas, K., Low, N.C., Von Korff, M., Kessler, R.C., Impact of comorbidity on headache-related disability. Neurology 70:7 (2008), 538–547.
41. 41 Zwart, J.A., Dyb, G., Hagen, K., et al. Depression and anxiety disorders associated with headache frequency: the Nord-Trøndelag Health Study. Eur J Neurol 10:2 (2003), 147–152.
42. 42 Clemens, J.Q., Brown, S.O., Calhoun, E.A., Mental health diagnoses in patients with interstitial cystitis/painful bladder syndrome and chronic prostatitis/chronic pelvic pain syndrome: a case/control study. J Urol 180:4 (2008), 1378–1382.
43. 43 Masheb, R.M., Wang, E., Lozano, C., Kerns, R.D., Prevalence and correlates of depression in treatment-seeking women with vulvodynia. J Obstet Gynaecol 25:8 (2005), 786–791.
44. 44 Nickel, J.C., Tripp, D.A., International Interstitial Cystitis Study Group. Clinical and psychological parameters associated with pain pattern phenotypes in women with interstitial cystitis/bladder pain syndrome. J Urol 193:1 (2015), 138–144.
45. 45 Riegel, B., Bruenahl, C.A., Ahyai, S., Bingel, U., Fisch, M., Löwe, B., Assessing psychological factors, social aspects and psychiatric co-morbidity associated with Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) in men—a systematic review. J Psychosom Res 77:5 (2014), 333–350.
46. 46 Samplaski, M.K., Li, J., Shoskes, D.A., Clustering of UPOINT domains and subdomains in men with chronic prostatitis/chronic pelvic pain syndrome and contribution to symptom severity. J Urol 188:5 (2012), 1788–1793.
47. 47 Matcham, F., Rayner, L., Steer, S., Hotopf, M., The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology (Oxford) 52:12 (2013), 2136–2148.
48. 48 Murphy, L.B., Sacks, J.J., Brady, T.J., Hootman, J.M., Chapman, D.P., Anxiety and depression among US adults with arthritis: prevalence and correlates. Arthritis Care Res (Hoboken) 64:7 (2012), 968–976.
49. 49 Stang, P.E., Brandenburg, N.A., Lane, M.C., Merikangas, K.R., Von Korff, M.R., Kessler, R.C., Mental and physical comorbid conditions and days in role among persons with arthritis. Psychosom Med 68:1 (2006), 152–158.
50. 50 Burris, J.L., Cyders, M.A., de Leeuw, R., Smith, G.T., Carlson, C.R., Posttraumatic stress disorder symptoms and chronic orofacial pain: an empirical examination of the mutual maintenance model. J Orofac Pain 23:3 (2009), 243–252.
51. 51 De Leeuw, R., Bertoli, E., Schmidt, J.E., Carlson, C.R., Prevalence of post-traumatic stress disorder symptoms in orofacial pain patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 99:5 (2005), 558–568.
52. 52 Monteiro, D.R., Zuim, P.R., Pesqueira, A.A., Ribeiro Pdo, P., Garcia, A.R., Relationship between anxiety and chronic orofacial pain of temporomandibular disorder in a group of university students. J Prosthodont Res 55:3 (2011), 154–158.
53. 53 Lamvu, G., Nguyen, R.H., Burrows, L.J., et al. The evidence-based Vulvodynia Assessment Project: a national registry for the study of vulvodynia. J Reprod Med 60:5-6 (2015), 223–235.
54. 54 Alonso-Morán, E., Orueta, J.F., Fraile Esteban, J.I., et al. The prevalence of diabetes-related complications and multimorbidity in the population with type 2 diabetes mellitus in the Basque Country. BMC Public Health, 14, 2014, 1059.
55. 55 Dermanovic Dobrota, V., Hrabac, P., Skegro, D., et al. The impact of neuropathic pain and other comorbidities on the quality of life in patients with diabetes. Health Qual Life Outcomes, 12, 2014, 171.
56. 56 Zhao, Y., Liu, J., Zhao, Y., Thethi, T., Fonseca, V., Shi, L., Predictors of duloxetine versus other treatments among veterans with diabetic peripheral neuropathic pain: a retrospective study. Pain Pract 12:5 (2012), 366–373.
57. 57 Ciaramella, A., Poli, P., Chronic low back pain: perception and coping with pain in the presence of psychiatric comorbidity. J Nerv Ment Dis 203:8 (2015), 632–640.
58. 58 Janssens, K.A., Zijlema, W.L., Joustra, M.L., Rosmalen, J.G., Mood and anxiety disorders in chronic fatigue syndrome, fibromyalgia, and irritable bowel syndrome: results from the LifeLines Cohort Study. Psychosom Med 77:4 (2015), 449–457.
59. 59 Carroll, L.J., Cassidy, J.D., Côté, P., Factors associated with the onset of an episode of depressive symptoms in the general population. J Clin Epidemiol 56:7 (2003), 651–658.
60. 60 Carroll, L.J., Cassidy, J.D., Côté, P., Depression as a risk factor for onset of an episode of troublesome neck and low back pain. Pain 107:1-2 (2004), 134–139.
61. 61 Currie, S.R., Wang, J., Chronic back pain and major depression in the general Canadian population. Pain 107:1-2 (2004), 54–60.
62. 62 Currie, S.R., Wang, J., More data on major depression as an antecedent risk factor for first onset of chronic back pain. Psychol Med 35:9 (2005), 1275–1282.
63. 63 Baliki, M.N., Chialvo, D.R., Geha, P.Y., et al. Chronic pain and the emotional brain: specific brain activity associated with spontaneous fluctuations of intensity of chronic back pain. J Neurosci 26:47 (2006), 12165–12173.
64. 64 Berman, S.M., Naliboff, B.D., Suyenobu, B., et al. Reduced brainstem inhibition during anticipated pelvic visceral pain correlates with enhanced brain response to the visceral stimulus in women with irritable bowel syndrome. J Neurosci 28:2 (2008), 349–359.
65. 65 Jensen, K.B., Kosek, E., Petzke, F., et al. Evidence of dysfunctional pain inhibition in fibromyalgia reflected in rACC during provoked pain. Pain 144:1-2 (2009), 95–100.
66. 66 Hashmi, J.A., Baliki, M.N., Huang, L., et al. Shape shifting pain: chronification of back pain shifts brain representation from nociceptive to emotional circuits. Brain 136:pt 9 (2013), 2751–2768.
67. 67 Diener, C., Kuehner, C., Brusniak, W., Ubl, B., Wessa, M., Flor, H., A meta-analysis of neurofunctional imaging studies of emotion and cognition in major depression. Neuroimage 61:3 (2012), 677–685.
68. 68 Mutschler, I., Ball, T., Wankerl, J., Strigo, I.A., Pain and emotion in the insular cortex: evidence for functional reorganization in major depression. Neurosci Lett 520:2 (2012), 204–209.
69. 69 Bruffaerts, R., Demyttenaere, K., Kessler, R.C., et al. The associations between preexisting mental disorders and subsequent onset of chronic headaches: a worldwide epidemiologic perspective. J Pain 16:1 (2015), 42–52.
70. 70 Hsieh, J.C., Hannerz, J., Ingvar, M., Right-lateralised central processing for pain of nitroglycerin-induced cluster headache. Pain 67:1 (1996), 59–68.
71. 71 Davidson, R.J., Abercrombie, H., Nitschke, J.B., Putnam, K., Regional brain function, emotion and disorders of emotion. Curr Opin Neurobiol 9:2 (1999), 228–234.
72. 72 Rosen, S.D., Paulesu, E., Frith, C.D., et al. Central nervous pathways mediating angina pectoris. Lancet 344:8916 (1994), 147–150.
73. 73 Compton, W.M., Jones, C.M., Baldwin, G.T., Relationship between nonmedical prescription-opioid use and heroin use. N Engl J Med 374:2 (2016), 154–163.
74. 74 Dart, R.C., Surratt, H.L., Cicero, T.J., et al. Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med 372:3 (2015), 241–248.
75. 75 Martell, B.A., O'Connor, P.G., Kerns, R.D., et al. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med 146:2 (2007), 116–127.
76. 76 Vowles, K.E., McEntee, M.L., Julnes, P.S., Frohe, T., Ney, J.P., van der Goes, D.N., Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain 156:4 (2015), 569–576.
77. 77 Boscarino, J.A., Hoffman, S.N., Han, J.J., Opioid-use disorder among patients on long-term opioid therapy: impact of final DSM-5 diagnostic criteria on prevalence and correlates. Subst Abuse Rehabil 6 (2015), 83–91.
78. 78 Boscarino, J.A., Rukstalis, M., Hoffman, S.N., et al. Risk factors for drug dependence among out-patients on opioid therapy in a large US health-care system. Addiction 105:10 (2010), 1776–1782.
79. 79 Boscarino, J.A., Rukstalis, M.R., Hoffman, S.N., et al. Prevalence of prescription opioid-use disorder among chronic pain patients: comparison of the DSM-5 vs. DSM-4 diagnostic criteria. J Addict Dis 30:3 (2011), 185–194.
80. 80 Reisfield, G.M., Wasan, A.D., Jamison, R.N., The prevalence and significance of cannabis use in patients prescribed chronic opioid therapy: a review of the extant literature. Pain Med 10:8 (2009), 1434–1441.
81. 81 Alford, D.P., German, J.S., Samet, J.H., Cheng, D.M., Lloyd-Travaglini, C.A., Saitz, R., Primary care patients with drug use report chronic pain and self-medicate with alcohol and other drugs. J Gen Intern Med 31:5 (2016), 486–491.
82. 82 Jamison, R.N., Kauffman, J., Katz, N.P., Characteristics of methadone maintenance patients with chronic pain. J Pain Symptom Manage 19:1 (2000), 53–62.
83. 83 Rosenblum, A., Joseph, H., Fong, C., Kipnis, S., Cleland, C., Portenoy, R.K., Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA 289:18 (2003), 2370–2378.
84. 84 Tegethoff, M., Belardi, A., Stalujanis, E., Meinlschmidt, G., Comorbidity of mental disorders and chronic pain: chronology of onset in adolescents of a national representative cohort. J Pain 16:10 (2015), 1054–1064.
85. 85 Scott, K.M., Lim, C., Al-Hamzawi, A., et al. Association of mental disorders with subsequent chronic physical conditions: World Mental Health surveys from 17 countries. JAMA Psychiatry 73:2 (2016), 150–158.
86. 86 Kalivas, P.W., Volkow, N.D., The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 162:8 (2005), 1403–1413.
87. 87 Morales, M., Pickel, V.M., Insights to drug addiction derived from ultrastructural views of the mesocorticolimbic system. Ann N Y Acad Sci 1248 (2012), 71–88.
88. 88 Apkarian, A.V., Neugebauer, V., Koob, G., et al. Neural mechanisms of pain and alcohol dependence. Pharmacol Biochem Behav 112 (2013), 34–41.
89. 89 Egli, M., Koob, G.F., Edwards, S., Alcohol dependence as a chronic pain disorder. Neurosci Biobehav Rev 36:10 (2012), 2179–2192.
90. 90 Joseph, E.K., Reichling, D.B., Levine, J.D., Shared mechanisms for opioid tolerance and a transition to chronic pain. J Neurosci 30:13 (2010), 4660–4666.
91. 91 Centers for Disease Control and Prevention, National Center for Injury and Prevention and Control. Web-based Injury Statistics Query and Reporting System (WISQARS). http://www.cdc.gov/injury/wisqars/pdfleading_causes_of_death_by_age_group_2013-a.pdf. Accessed June 1, 2016.
92. 92 Hassett, A.L., Aquino, J.K., Ilgen, M.A., The risk of suicide mortality in chronic pain patients. Curr Pain Headache Rep, 18(8), 2014, 436.
93. 93 Ilgen, M.A., Zivin, K., Austin, K.L., et al. Severe pain predicts greater likelihood of subsequent suicide. Suicide Life Threat Behav 40:6 (2010), 597–608.
94. 94 Cheatle, M.D., Wasser, T., Foster, C., Olugbodi, A., Bryan, J., Prevalence of suicidal ideation in patients with chronic non-cancer pain referred to a behaviorally based pain program. Pain Physician 17:3 (2014), E359–E367.
95. 95 Calandre, E.P., Navajas-Rojas, M.A., Ballesteros, J., Garcia-Carrillo, J., Garcia-Leiva, J.M., Rico-Villademoros, F., Suicidal ideation in patients with fibromyalgia: a cross-sectional study. Pain Pract 15:2 (2015), 168–174.
96. 96 Triñanes, Y., González-Villar, A., Gómez-Perretta, C., Carrillo-de-la-Peña, M.T., Suicidality in chronic pain: predictors of suicidal ideation in fibromyalgia. Pain Pract 15:4 (2015), 323–332.
97. 97 Calati, R., Laglaoui Bakhiyi, C., Artero, S., Ilgen, M., Courtet, P., The impact of physical pain on suicidal thoughts and behaviors: meta-analyses. J Psychiatr Res 71 (2015), 16–32.
98. 98 Breiding, M.J., Smith, S.G., Basile, K.C., Walters, M.L., Chen, J., Merrick, M.T., Prevalence and characteristics of sexual violence, stalking, and intimate partner violence victimization—national intimate partner and sexual violence survey, United States, 2011. MMWR Surveill Summ 63:8 (2014), 1–18.
99. 99 Afari, N., Ahumada, S.M., Wright, L.J., et al. Psychological trauma and functional somatic syndromes: a systematic review and meta-analysis. Psychosom Med 76:1 (2014), 2–11.
100. 100 Paras, M.L., Murad, M.H., Chen, L.P., et al. Sexual abuse and lifetime diagnosis of somatic disorders: a systematic review and meta-analysis. JAMA 302:5 (2009), 550–561.
101. 101 Ehlert, U., Enduring psychobiological effects of childhood adversity. Psychoneuroendocrinology 38:9 (2013), 1850–1857.
102. 102 Spiegel, D.R., Shaukat, A.M., Mccroskey, A.L., et al. Conceptualizing a subtype of patients with chronic pain: the necessity of obtaining a history of sexual abuse. Int J Psychiatry Med 51:1 (2016), 84–103.
103. 103 Evers, A.W., Kraaimaat, F.W., van Riel, P.L., Bijlsma, J.W., Cognitive, behavioral and physiological reactivity to pain as a predictor of long-term pain in rheumatoid arthritis patients. Pain 93:2 (2001), 139–146.
104. 104 Cvijetic, S., Bobic, J., Grazio, S., Uremovic, M., Nemcic, T., Krapac, L., Quality of life, personality and use of pain medication in patients with chronic back pain. Appl Res Qual Life 9:2 (2014), 401–411.
105. 105 Ramírez-Maestre, C., López Martínez, A.E., Zarazaga, R.E., Personality characteristics as differential variables of the pain experience. J Behav Med 27:2 (2004), 147–165.
106. 106 Harkins, S.W., Price, D.D., Braith, J., Effects of extraversion and neuroticism on experimental pain, clinical pain, and illness behavior. Pain 36:2 (1989), 209–218.
107. 107 Kadimpati, S., Zale, E.L., Hooten, W.M., Ditre, J.W., Warner, D.O., Correction: associations between neuroticism and depression in relation to catastrophizing and pain-related anxiety in chronic pain patients. PLoS One, 10(6), 2015, e0129871.
108. 108 Tyrer, P., Reed, G.M., Crawford, M.J., Classification, assessment, prevalence, and effect of personality disorder. Lancet 385:9969 (2015), 717–726.
109. 109 Weisberg, J.N., Personality and personality disorders in chronic pain. Curr Rev Pain 4:1 (2000), 60–70.
110. 110 Dixon-Gordon, K.L., Turner, B.J., Chapman, A.L., Psychotherapy for personality disorders. Int Rev Psychiatry 23:3 (2011), 282–302.
111. 111 Agaku, I.T., King, B.A., Dube, S.R., Centers for Disease Control and Prevention (CDC). Current cigarette smoking among adults—United States, 2005-2012. MMWR Morb Mortal Wkly Rep 63:2 (2014), 29–34.
112. 112 Orhurhu, V.J., Pittelkow, T.P., Hooten, W.M., Prevalence of smoking in adults with chronic pain. Tob Induc Dis, 13(1), 2015, 17.
113. 113 Centers for Disease Control and Prevention (CDC). Vital signs: current cigarette smoking among adults aged ≥18 years—United States, 2005-2010. MMWR Morb Mortal Wkly Rep 60:35 (2011), 1207–1212.
114. 114 Hooten, W.M., Shi, Y., Gazelka, H.M., Warner, D.O., The effects of depression and smoking on pain severity and opioid use in patients with chronic pain. Pain 152:1 (2011), 223–229.
115. 115 Hooten, W.M., Townsend, C.O., Bruce, B.K., et al. Effects of smoking status on immediate treatment outcomes of multidisciplinary pain rehabilitation. Pain Med 10:2 (2009), 347–355.
116. 116 Hooten, W.M., Townsend, C.O., Bruce, B.K., Shi, Y., Warner, D.O., Sex differences in characteristics of smokers with chronic pain undergoing multidisciplinary pain rehabilitation. Pain Med 10:8 (2009), 1416–1425.
117. 117 Hooten, W.M., Townsend, C.O., Bruce, B.K., Warner, D.O., The effects of smoking status on opioid tapering among patients with chronic pain. Anesth Analg 108:1 (2009), 308–315.
118. 118 Kishioka, S., Kiguchi, N., Kobayashi, Y., Saika, F., Nicotine effects and the endogenous opioid system. J Pharmacol Sci 125:2 (2014), 117–124.
119. 119 Hooten, W.M., Vickers, K.S., Shi, Y., et al. Smoking cessation and chronic pain: patient and pain medicine physician attitudes. Pain Pract 11:6 (2011), 552–563.
120. 120 Hooten, W.M., Townsend, C.O., Hays, J.T., et al. A cognitive behavioral smoking abstinence intervention for adults with chronic pain: a randomized controlled pilot trial. Addict Behav 39:3 (2014), 593–599.
121. 121 Vlaeyen, J.W., Linton, S.J., Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art. Pain 85:3 (2000), 317–332.
122. 122 Linton, S.J., Shaw, W.S., Impact of psychological factors in the experience of pain. Phys Ther 91:5 (2011), 700–711.
123. 123 Lloyd, D.M., Helbig, T., Findlay, G., Roberts, N., Nurmikko, T., Brain areas involved in anticipation of clinically-relevant pain in low back pain populations with high levels of pain behaviour. J Pain 17:5 (2016), 577–587.
124. 124 Otis, J.D., Pincus, D.B., Murawski, M.E., Cognitive behavioral therapy in pain management. Ebert, M.H., Kerns, R.D., (eds.) Behavioral and Psychopharmacologic Pain Management, 2011, Cambridge University Press, Cambridge, UK, 184–200.
125. 125 Pence, L.E., Thorn, B.E., Davis, A.M., Cognitive coping strategies in pain management. Ebert, M.H., Kerns, R.D., (eds.) Behavioral and Psychopharmacologic Pain Management, 2011, Cambridge University Press, Cambridge, UK, 214–235.
126. 126 Bernardy, K., Füber, N., Köllner, V., Häuser, W., Efficacy of cognitive-behavioral therapies in fibromyalgia syndrome—a systematic review and metaanalysis of randomized controlled trials. J Rheumatol 37:10 (2010), 1991–2005.
127. 127 Butler, A.C., Chapman, J.E., Forman, E.M., Beck, A.T., The empirical status of cognitive-behavioral therapy: a review of meta-analyses. Clin Psychol Rev 26:1 (2006), 17–31.
128. 128 Richmond, H., Hall, A.M., Copsey, B., et al. The effectiveness of cognitive behavioural treatment for non-specific low back pain: a systematic review and meta-analysis. PLoS One, 10(8), 2015, e0134192.
129. 129 Jensen, K.B., Kosek, E., Wicksell, R., et al. Cognitive behavioral therapy increases pain-evoked activation of the prefrontal cortex in patients with fibromyalgia. [published correction appears in Pain. 2012;153(9):1982] Pain 153:7 (2012), 1495–1503.
130. 130 Hayes, S.C., Levin, M.E., Plumb-Vilardaga, J., Villatte, J.L., Pistorello, J., Acceptance and commitment therapy and contextual behavioral science: examining the progress of a distinctive model of behavioral and cognitive therapy. Behav Ther 44:2 (2013), 180–198.
131. 131 Veehof, M.M., Oskam, M.J., Schreurs, K.M., Bohlmeijer, E.T., Acceptance-based interventions for the treatment of chronic pain: a systematic review and meta-analysis. Pain 152:3 (2011), 533–542.
132. 132 Veehof, M.M., Trompetter, H.R., Bohlmeijer, E.T., Schreurs, K.M., Acceptance- and mindfulness-based interventions for the treatment of chronic pain: a meta-analytic review. Cogn Behav Ther 45:1 (2016), 5–31.
133. 133 Goyal, M., Singh, S., Sibinga, E.M., et al. Meditation programs for psychological stress and well-being: a systematic review and meta-analysis. JAMA Intern Med 174:3 (2014), 357–368.
134. 134 Bawa, F.L., Mercer, S.W., Atherton, R.J., et al. Does mindfulness improve outcomes in patients with chronic pain? Systematic review and meta-analysis. Br J Gen Pract 65:635 (2015), e387–e400.
135. 135 Tang, Y.Y., Hölzel, B.K., Posner, M.I., The neuroscience of mindfulness meditation. Nat Rev Neurosci 16:4 (2015), 213–225.
136. 136 Townsend, C.O., Bruce, B.K., Hooten, W.M., Rome, J.D., The role of mental health professionals in multidisciplinary pain rehabilitation programs. J Clin Psychol 62:11 (2006), 1433–1443.
137. 137 Berna, C., Kulich, R.J., Rathmell, J.P., Tapering long-term opioid therapy in chronic noncancer pain: evidence and recommendations for everyday practice. Mayo Clin Proc 90:6 (2015), 828–842.
138. 138 Kamper, S.J., Apeldoorn, A.T., Chiarotto, A., et al. Multidisciplinary biopsychosocial rehabilitation for chronic low back pain: Cochrane systematic review and meta-analysis. BMJ, 350, 2015, h444.
139. 139 Sletten, C.D., Kurklinsky, S., Chinburapa, V., Ghazi, S., Economic analysis of a comprehensive pain rehabilitation program: a collaboration between Florida Blue and Mayo Clinic Florida. Pain Med 16:5 (2015), 898–904.
140. 140 Hooten, W.M., Qu, W., Townsend, C.O., Judd, J.W., Effects of strength vs aerobic exercise on pain severity in adults with fibromyalgia: a randomized equivalence trial. Pain 153:4 (2012), 915–923.
141. 141 Hooten, W.M., Rosenberg, C.J., Eldrige, J.S., Qu, W., Knee extensor strength is associated with pressure pain thresholds in adults with fibromyalgia. PLoS One, 8(4), 2013, e59930.
142. 142 Hooten, W.M., Smith, J.M., Eldrige, J.S., Olsen, D.A., Mauck, W.D., Moeschler, S.M., Pain severity is associated with muscle strength and peak oxygen uptake in adults with fibromyalgia. J Pain Res 7 (2014), 237–242.
143. 143 Cunningham, J.L., Rome, J.D., Kerkvliet, J.L., Townsend, C.O., Reduction in medication costs for patients with chronic nonmalignant pain completing a pain rehabilitation program: a prospective analysis of admission, discharge, and 6-month follow-up medication costs. Pain Med 10:5 (2009), 787–796.
144. 144 Hooten, W.M., Commentary: the paradox of analgesic medication elimination. Pain Med 10:5 (2009), 797–798.
145. 145 Crisostomo, R.A., Schmidt, J.E., Hooten, W.M., Kerkvliet, J.L., Townsend, C.O., Bruce, B.K., Withdrawal of analgesic medication for chronic low-back pain patients: improvement in outcomes of multidisciplinary rehabilitation regardless of surgical history. Am J Phys Med Rehabil 87:7 (2008), 527–536.
146. 146 Hooten, W.M., Townsend, C.O., Sletten, C.D., Bruce, B.K., Rome, J.D., Treatment outcomes after multidisciplinary pain rehabilitation with analgesic medication withdrawal for patients with fibromyalgia. Pain Med 8:1 (2007), 8–16.
147. 147 Townsend, C.O., Kerkvliet, J.L., Bruce, B.K., et al. A longitudinal study of the efficacy of a comprehensive pain rehabilitation program with opioid withdrawal: comparison of treatment outcomes based on opioid use status at admission. Pain 140:1 (2008), 177–189.
148. 148 Hochberg, M.C., Wohlreich, M., Gaynor, P., Hanna, S., Risser, R., Clinically relevant outcomes based on analysis of pooled data from 2 trials of duloxetine in patients with knee osteoarthritis. J Rheumatol 39:2 (2012), 352–358.
149. 149 Häuser, W., Petzke, F., Üçeyler, N., Sommer, C., Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: a systematic review with meta-analysis. Rheumatology (Oxford) 50:3 (2011), 532–543.
150. 150 Finnerup, N.B., Attal, N., Haroutounian, S., et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol 14:2 (2015), 162–173.
151. 151 Häuser, W., Bernardy, K., Uçeyler, N., Sommer, C., Treatment of fibromyalgia syndrome with gabapentin and pregabalin—a meta-analysis of randomized controlled trials. Pain 145:1-2 (2009), 69–81.
152. 152 Marangell, L.B., Clauw, D.J., Choy, E., et al. Comparative pain and mood effects in patients with comorbid fibromyalgia and major depressive disorder: secondary analyses of four pooled randomized controlled trials of duloxetine. Pain 152:1 (2011), 31–37.
153. 153 Häuser, W., Bernardy, K., Uçeyler, N., Sommer, C., Treatment of fibromyalgia syndrome with antidepressants: a meta-analysis. JAMA 301:2 (2009), 198–209.
154. 154 Wang, Z.Y., Shi, S.Y., Li, S.J., et al. Efficacy and safety of duloxetine on osteoarthritis knee pain: a meta-analysis of randomized controlled trials. Pain Med 16:7 (2015), 1373–1385.
155. 155 Bradley, A.J., Lenox-Smith, A.J., Does adding noradrenaline reuptake inhibition to selective serotonin reuptake inhibition improve efficacy in patients with depression? A systematic review of meta-analyses and large randomised pragmatic trials. J Psychopharmacol 27:8 (2013), 740–758.
156. 156 Dell'Osso, B., Buoli, M., Baldwin, D.S., Altamura, A.C., Serotonin norepinephrine reuptake inhibitors (SNRIs) in anxiety disorders: a comprehensive review of their clinical efficacy. Hum Psychopharmacol 25:1 (2010), 17–29.
157. 157 Fishbain, D.A., Cole, B., Lewis, J.E., Gao, J., Does pain interfere with antidepressant depression treatment response and remission in patients with depression and pain? An evidence-based structured review. Pain Med 15:9 (2014), 1522–1539.
158. 158 Kroenke, K., Bair, M.J., Damush, T.M., et al. Optimized antidepressant therapy and pain self-management in primary care patients with depression and musculoskeletal pain: a randomized controlled trial. JAMA 301:20 (2009), 2099–2110.
159. 159 López-Solà, M., Pujol, J., Hernández-Ribas, R., et al. Effects of duloxetine treatment on brain response to painful stimulation in major depressive disorder. Neuropsychopharmacology 35:11 (2010), 2305–2317.
160. 160 Mainguy, Y., Functional magnetic resonance imagery (fMRI) in fibromyalgia and the response to milnacipran. Hum Psychopharmacol 24:suppl 1 (2009), S19–S23.
161. 161 Dick, I.E., Brochu, R.M., Purohit, Y., Kaczorowski, G.J., Martin, W.J., Priest, B.T., Sodium channel blockade may contribute to the analgesic efficacy of antidepressants. J Pain 8:4 (2007), 315–324.
162. 162 Li, Y.F., Zhang, Y.Z., Liu, Y.Q., et al. Inhibition of N-methyl-d-aspartate receptor function appears to be one of the common actions for antidepressants. J Psychopharmacol 20:5 (2006), 629–635.
163. 163 Benbouzid, M., Gavériaux-Ruff, C., Yalcin, I., et al. Delta-opioid receptors are critical for tricyclic antidepressant treatment of neuropathic allodynia. Biol Psychiatry 63:6 (2008), 633–636.
164. 164 Tata, L.J., West, J., Smith, C., et al. General population based study of the impact of tricyclic and selective serotonin reuptake inhibitor antidepressants on the risk of acute myocardial infarction. Heart 91:4 (2005), 465–471.
165. 165 Ray, W.A., Meredith, S., Thapa, P.B., Hall, K., Murray, K.T., Cyclic antidepressants and the risk of sudden cardiac death. Clin Pharmacol Ther 75:3 (2004), 234–241.
166. 166 Staiger, T.O., Gaster, B., Sullivan, M.D., Deyo, R.A., Systematic review of antidepressants in the treatment of chronic low back pain. Spine (Phila Pa 1976) 28:22 (2003), 2540–2545.
167. 167 Morgan, V., Pickens, D., Gautam, S., Kessler, R., Mertz, H., Amitriptyline reduces rectal pain related activation of the anterior cingulate cortex in patients with irritable bowel syndrome. Gut 54:5 (2005), 601–607.
168. 168 Perna, G., Alciati, A., Riva, A., Micieli, W., Caldirola, D., Long-term pharmacological treatments of anxiety disorders: an updated systematic review. Curr Psychiatry Rep, 18(3), 2016, 23.
169. 169 Berlin, R.K., Butler, P.M., Perloff, M.D., Gabapentin therapy in psychiatric disorders: a systematic review. Prim Care Companion CNS Disord, 17(5), 2015.
170. 170 Harris, R.E., Napadow, V., Huggins, J.P., et al. Pregabalin rectifies aberrant brain chemistry, connectivity, and functional response in chronic pain patients. Anesthesiology 119:6 (2013), 1453–1464.
171. 171 Boyer, E.W., Shannon, M., The serotonin syndrome. [published corrections appear in N Engl J Med. 2007;356(23):2437 and N Engl J Med. 2009;361(17):1714] N Engl J Med 352:11 (2005), 1112–1120.
172. 172 Gillman, P.K., A review of serotonin toxicity data: implications for the mechanisms of antidepressant drug action. Biol Psychiatry 59:11 (2006), 1046–1051.
173. 173 Black, K., Shea, C., Dursun, S., Kutcher, S., Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria. J Psychiatry Neurosci 25:3 (2000), 255–261.
174. 174 Sharma, T., Guski, L.S., Freund, N., Gøtzsche, P.C., Suicidality and aggression during antidepressant treatment: systematic review and meta-analyses based on clinical study reports. BMJ, 352, 2016, i65.
175. 175 Patorno, E., Bohn, R.L., Wahl, P.M., et al. Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death. [published correction appears in JAMA. 2010;303(22):2252. Dosage error in article text] JAMA 303:14 (2010), 1401–1409.